84 related articles for article (PubMed ID: 21413004)
1. Expression of IL-10-triggered STAT3-dependent IL-4Rα is required for induction of arginase 1 in visceral leishmaniasis.
Biswas A; Bhattacharya A; Kar S; Das PK
Eur J Immunol; 2011 Apr; 41(4):992-1003. PubMed ID: 21413004
[TBL] [Abstract][Full Text] [Related]
2. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S
Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity.
Sharkhuu T; Matthaei KI; Forbes E; Mahalingam S; Hogan SP; Hansbro PM; Foster PS
Clin Exp Allergy; 2006 Dec; 36(12):1575-83. PubMed ID: 17177681
[TBL] [Abstract][Full Text] [Related]
4. Growth factor and Th2 cytokine signaling pathways converge at STAT6 to promote arginase expression in progressive experimental visceral leishmaniasis.
Osorio EY; Travi BL; da Cruz AM; Saldarriaga OA; Medina AA; Melby PC
PLoS Pathog; 2014 Jun; 10(6):e1004165. PubMed ID: 24967908
[TBL] [Abstract][Full Text] [Related]
5. Progressive visceral leishmaniasis is driven by dominant parasite-induced STAT6 activation and STAT6-dependent host arginase 1 expression.
Osorio EY; Zhao W; Espitia C; Saldarriaga O; Hawel L; Byus CV; Travi BL; Melby PC
PLoS Pathog; 2012 Jan; 8(1):e1002417. PubMed ID: 22275864
[TBL] [Abstract][Full Text] [Related]
6. Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling.
Mohrs M; Ledermann B; Köhler G; Dorfmüller A; Gessner A; Brombacher F
J Immunol; 1999 Jun; 162(12):7302-8. PubMed ID: 10358179
[TBL] [Abstract][Full Text] [Related]
7. Immunohistological features of visceral leishmaniasis in BALB/c mice.
Carrión J; Nieto A; Iborra S; Iniesta V; Soto M; Folgueira C; Abanades DR; Requena JM; Alonso C
Parasite Immunol; 2006 May; 28(5):173-83. PubMed ID: 16629702
[TBL] [Abstract][Full Text] [Related]
8. Expression of IL-4 receptor on non-bone marrow-derived cells is necessary for the timely elimination of Strongyloides venezuelensis in mice, but not for intestinal IL-4 production.
Negrão-Corrêa D; Pinho V; Souza DG; Pereira AT; Fernandes A; Scheuermann K; Souza AL; Teixeira MM
Int J Parasitol; 2006 Sep; 36(10-11):1185-95. PubMed ID: 16793046
[TBL] [Abstract][Full Text] [Related]
9. IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains.
Noben-Trauth N; Paul WE; Sacks DL
J Immunol; 1999 May; 162(10):6132-40. PubMed ID: 10229856
[TBL] [Abstract][Full Text] [Related]
10. MAPK-directed phosphatases preferentially regulate pro- and anti-inflammatory cytokines in experimental visceral leishmaniasis: involvement of distinct protein kinase C isoforms.
Kar S; Ukil A; Sharma G; Das PK
J Leukoc Biol; 2010 Jul; 88(1):9-20. PubMed ID: 20200403
[TBL] [Abstract][Full Text] [Related]
11. Control of Schistosoma mansoni egg-induced inflammation by IL-4-responsive CD4(+)CD25(-)CD103(+)Foxp3(-) cells is IL-10-dependent.
Dewals B; Hoving JC; Horsnell WG; Brombacher F
Eur J Immunol; 2010 Oct; 40(10):2837-47. PubMed ID: 20821727
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology.
Rosas LE; Satoskar AA; Roth KM; Keiser TL; Barbi J; Hunter C; de Sauvage FJ; Satoskar AR
Am J Pathol; 2006 Jan; 168(1):158-69. PubMed ID: 16400019
[TBL] [Abstract][Full Text] [Related]
13. WSX-1 over-expression in CD4(+) T cells leads to hyperproliferation and cytokine hyperproduction in response to TCR stimulation.
Takeda A; Hamano S; Shiraishi H; Yoshimura T; Ogata H; Ishii K; Ishibashi T; Yoshimura A; Yoshida H
Int Immunol; 2005 Jul; 17(7):889-97. PubMed ID: 15908443
[TBL] [Abstract][Full Text] [Related]
14. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.
Liese J; Schleicher U; Bogdan C
Eur J Immunol; 2007 Dec; 37(12):3424-34. PubMed ID: 18034422
[TBL] [Abstract][Full Text] [Related]
15. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
Melby PC; Yang J; Zhao W; Perez LE; Cheng J
Infect Immun; 2001 Aug; 69(8):4719-25. PubMed ID: 11447143
[TBL] [Abstract][Full Text] [Related]
16. Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis.
Murray HW; Moreira AL; Lu CM; DeVecchio JL; Matsuhashi M; Ma X; Heinzel FP
J Infect Dis; 2003 Aug; 188(3):458-64. PubMed ID: 12870129
[TBL] [Abstract][Full Text] [Related]
17. BCL-6-deficient mice reveal an IL-4-independent, STAT6-dependent pathway that controls susceptibility to infection by Leishmania major.
Dent AL; Doherty TM; Paul WE; Sher A; Staudt LM
J Immunol; 1999 Aug; 163(4):2098-103. PubMed ID: 10438949
[TBL] [Abstract][Full Text] [Related]
18. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani.
Reiner NE
J Immunol; 1987 Mar; 138(6):1919-25. PubMed ID: 3493291
[TBL] [Abstract][Full Text] [Related]
19. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
20. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis.
Kaye PM; Curry AJ; Blackwell JM
J Immunol; 1991 Apr; 146(8):2763-70. PubMed ID: 1901883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
